Log in to save to my catalogue

SAT0368 GO-DACT: A RANDOMIZED DOUBLE-BLIND PLACEBO-CONTROLED PROOF-OF-CONCEPT TRIAL OF GOLIMUMAB PLU...

SAT0368 GO-DACT: A RANDOMIZED DOUBLE-BLIND PLACEBO-CONTROLED PROOF-OF-CONCEPT TRIAL OF GOLIMUMAB PLU...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_crossref_primary_10_1136_annrheumdis_2019_eular_5164

SAT0368 GO-DACT: A RANDOMIZED DOUBLE-BLIND PLACEBO-CONTROLED PROOF-OF-CONCEPT TRIAL OF GOLIMUMAB PLUS METHOTREXATE (MTX) VERSUS MTX MONOTHERAPY, IN IMPROVING DACTYLITIS, IN MTX NAïVE PSORIATIC ARTHRITIS PATIENTS

About this item

Full title

SAT0368 GO-DACT: A RANDOMIZED DOUBLE-BLIND PLACEBO-CONTROLED PROOF-OF-CONCEPT TRIAL OF GOLIMUMAB PLUS METHOTREXATE (MTX) VERSUS MTX MONOTHERAPY, IN IMPROVING DACTYLITIS, IN MTX NAïVE PSORIATIC ARTHRITIS PATIENTS

Journal title

Annals of the rheumatic diseases, 2019-06, Vol.78, p.1266

Language

English

Formats

More information

Alternative Titles

Full title

SAT0368 GO-DACT: A RANDOMIZED DOUBLE-BLIND PLACEBO-CONTROLED PROOF-OF-CONCEPT TRIAL OF GOLIMUMAB PLUS METHOTREXATE (MTX) VERSUS MTX MONOTHERAPY, IN IMPROVING DACTYLITIS, IN MTX NAïVE PSORIATIC ARTHRITIS PATIENTS

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_crossref_primary_10_1136_annrheumdis_2019_eular_5164

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_crossref_primary_10_1136_annrheumdis_2019_eular_5164

Other Identifiers

ISSN

0003-4967

DOI

10.1136/annrheumdis-2019-eular.5164

How to access this item